A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06161532

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:02.940981+00:00

Published At

2026-04-24T00:00:00+00:00

Record Updated At

2026-04-24

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Small Cell Carcinoma of the Bladder", "Small Cell Carcinoma of the Urinary Tract", "Squamous Cell Carcinoma of the Bladder", "Squamous Cell Carcinoma of the Urinary Tract", "Primary Adenocarcinoma of the Bladder", "Primary Adenocarcinoma of the Urinary Tract", "Renal Medullary Carcinoma", "Squamous Cell Carcinoma of the Penis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-24"

protocolSection.identificationModule.nctId

"NCT06161532"

protocolSection.identificationModule.officialTitle

"A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Small Cell Carcinoma of the Bladder (protocolSection.conditionsModule.conditions)
• Small Cell Carcinoma of the Urinary Tract (protocolSection.conditionsModule.conditions)
• Squamous Cell Carcinoma of the Bladder (protocolSection.conditionsModule.conditions)
• Squamous Cell Carcinoma of the Urinary Tract (protocolSection.conditionsModule.conditions)
• Primary Adenocarcinoma of the Bladder (protocolSection.conditionsModule.conditions)
• Primary Adenocarcinoma of the Urinary Tract (protocolSection.conditionsModule.conditions)
• Renal Medullary Carcinoma (protocolSection.conditionsModule.conditions)
• Squamous Cell Carcinoma of the Penis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.